Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman, Sandra M. Swain, Thomas M. Pisansky, Louis Fehrenbacher, Leila A. Kutteh, Victor G. Vogel, Daniel W. Visscher, Greg Yothers, Robert B. Jenkins, Ann M. Brown, Shaker R. DakhilEleftherios P. Mamounas, Wilma L. Lingle, Pamela M. Klein, James N. Ingle, Norman Wolmark

Research output: Contribution to journalArticlepeer-review

4185 Scopus citations

Fingerprint Dive into the research topics of 'Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences